Structure-activity relationships of αS1-casomorphin using AM1 calculations and molecular dynamics simulations

被引:3
作者
Wu, Yng-Ching
Lin, Jenn-Sen
Hwang, Chi-Chuan [1 ]
机构
[1] Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan
[2] Natl United Univ, Dept Mech Engn, Miaoli 36003, Taiwan
关键词
D O I
10.1021/jp070477y
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
This paper investigates the structure-activity relationships of alpha(S1)-casomorphin (alpha(S1)-CM) using AM1 calculations and molecular dynamics (MD) simulations. Previous studies have shown that this peptide has remarkable opioid actions, and not only has a high affinity toward all three subtypes (kappa(1)-kappa(3)) of the kappa-opioid sites, but also inhibits the proliferation of the T47D human breast cancer cell line. The systematic conformer search performed by the AM1 calculations is based on the torsional angles of the Val(2)-Pro(3) (omega(2)) and Phe(4)-Pro(5) (omega(4)) amide bonds. The AM1 results reveal that the alpha(S1)-CM conformers strongly favor the cis/cis pair of the omega(2)/omega(4) amide bonds in the minimized energy state. Furthermore, the picture of these stable conformers is found to be a strong interaction of the coulomb's force between two terminuses. MD simulations are performed to investigate the features of both the structural stability and pharmacological activity of alpha(S1)-CM in aqueous solution. The simulation results reveal that the omega(2)/omega(4) amide bonds favor the cis/cis status in the stable state. Furthermore, the pharmacophoric distance between two aromatic rings is found to be 5.0 similar to 5.4A. The chi(1) rotamers of the Tyr and Phe residues show a preference for gauche (-) and trans, respectively. The side chain rotamers of alpha(S1)-CM are competed to those of other opioid ligands with a known potency and selectivity for delta- and mu-opioid receptors. Finally, we address a likely kappa pharmacophore model compared to the delta pharmacophore model.
引用
收藏
页码:7377 / 7383
页数:7
相关论文
共 47 条
[11]   The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors [J].
Hatzoglou, A ;
Bakogeorgou, E ;
Castanas, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 296 (02) :199-207
[12]   IDENTIFICATION AND CHARACTERIZATION OF OPIOID-BINDING SITES PRESENT IN THE ISHIKAWA HUMAN ENDOMETRIAL ADENOCARCINOMA CELL-LINE [J].
HATZOGLOU, A ;
GRAVANIS, A ;
MARGIORIS, AN ;
ZOUMAKIS, E ;
CASTANAS, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (02) :418-423
[13]   Mechanism of action of the diazabicyclononanone-type κ-agonists [J].
Holzgrabe, U ;
Brandt, W .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (08) :1383-1389
[14]   CHARACTERIZATION OF 3 TYPES OF HUMAN ALPHA(S1)-CASEIN MESSENGER-RNA TRANSCRIPTS [J].
JOHNSEN, LB ;
RASMUSSEN, LK ;
PETERSEN, TE ;
BERGLUND, L .
BIOCHEMICAL JOURNAL, 1995, 309 :237-242
[15]   Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors [J].
Kampa, M ;
Bakogeorgou, E ;
Hatzoglou, A ;
Damianaki, A ;
Martin, PM ;
Castanas, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 335 (2-3) :255-265
[16]   Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha(S1) casein (alpha(S1)-casomorphin, and alpha(S1)-casomorphin amide) [J].
Kampa, M ;
Loukas, S ;
Hatzoglou, A ;
Martin, P ;
Martin, PW ;
Castanas, E .
BIOCHEMICAL JOURNAL, 1996, 319 :903-908
[17]   Pseudoproline-containing analogues of morphiceptin and endomorphin-2:: Evidence for a cis Tyr-Pro amide bond in the bioactive conformation [J].
Keller, M ;
Boissard, C ;
Patiny, L ;
Chung, NN ;
Lemieux, C ;
Mutter, M ;
Schiller, PW .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (23) :3896-3903
[18]  
Ko MC, 1999, J PHARMACOL EXP THER, V289, P378
[19]   Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys [J].
Ko, MCH ;
Willmont, KJ ;
Burritt, A ;
Hruby, VJ ;
Wood, JH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 402 (1-2) :69-76
[20]   GROMACS 3.0: a package for molecular simulation and trajectory analysis [J].
Lindahl, E ;
Hess, B ;
van der Spoel, D .
JOURNAL OF MOLECULAR MODELING, 2001, 7 (08) :306-317